Congratulations Dr. Israel Abebe Admasu
He was a recipient of a fellowship award from the Association for Creatine Deficiencies. Dr. Admasu is a member of the Fagiolini lab. His work addresses the need for precise tools to evaluate emerging therapies for Cerebral Creatine Deficiency Syndromes (CCDS). His project establishes a non-invasive method to measure brain signals as biomarkers of disease severity, providing objective assessments for new treatments.
“I believe that my research will establish a critical framework for evaluating the potential impact and efficacy of upcoming therapeutic approaches targeting creatine deficiency syndromes,” said Dr. Admasu.
Recent Comments